Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
BIRC6
REST API REST API
Homo sapiens
BIRC6 is differentially expressed in 143 experiments: 56 organism parts: prostate, accumbens, ... (54 more);, 69 disease states: normal, breast carcinoma, ... (67 more);, 41 cell types 258 cell lines 15 compound treatments and 51 other conditions.
Synonyms BRUCE
Orthologs Birc6 (Mus musculus)   BIRC6 (Gallus gallus)   birc6 (Danio rerio)   D4A1E2_RAT (Rattus norvegicus)   Birc6 (Rattus norvegicus)   BIRC6 (Bos taurus)   Bruce (Drosophila melanogaster)   birc6 (Xenopus laevis)   BIRC6 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term ligase activity, protein binding, apoptosis, acid-amino acid ligase activity, regulation of cell proliferation, intracellular, positive regulation of cell proliferation, peptidase inhibitor activity, anti-apoptosis, membrane fraction, protein modification process, cysteine-type endopeptidase inhibitor activity, ubiquitin-protein ligase activity, cellular_component, protein transport, labyrinthine layer development, spongiotrophoblast layer development
InterPro Term UBQ-conjugat_E2, BIR, UEV_N, DUF3643
UniProt Accession Q9NR09
Search EB-eye ENSG00000115760
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-GEOD-6919, E-GEOD-3526, ... (14 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-22152, E-GEOD-19639, E-GEOD-24147, E-GEOD-19480, ... (17 experiments)

Factor Value U/D Experiments
A549
2
E-GEOD-6013, E-GEOD-3202
MCF-7
2
E-GEOD-20081, E-GEOD-19639
Toledo
1
E-MTAB-37
NA19130
1
E-GEOD-19480
NCIH522
1
E-MTAB-37
MOLT16
1
E-MTAB-37
252 more value(s).


Cell type

studied in E-GEOD-15893, E-AFMX-5, E-MEXP-2488, E-GEOD-22373, E-GEOD-21668, ... (20 experiments)

Factor Value U/D Experiments
CD326negCD56+ cell
1
1
E-GEOD-21668
CD34+ hematopoietic progenitor cell
1
1
E-GEOD-19240
centroblast
1
E-TABM-702
nucleus pulposus
1
E-MEXP-2488
spermatocyte
1
E-TABM-130
CD56+ NK cells
1
E-AFMX-5
35 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-MEXP-1121, E-MEXP-2069, ... (34 experiments)

Factor Value U/D Experiments
T-cell/histiocyte rich B cell lymphoma
1
E-GEOD-7788
colorectal adenocarcinoma
1
E-AFMX-5
leiomyosarcoma
1
E-MTAB-37
myeloma
1
E-MTAB-372
uterine fibroid
1
E-GEOD-7307
engineered invasive esophageal squamous cell carcinoma
1
E-GEOD-21293
63 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-20719, E-GEOD-15205, E-TABM-782, E-TABM-127, ... (9 experiments)

Factor Value U/D Experiments
estradiol
1
E-GEOD-20081
filtered air
1
E-TABM-127
1mM GDC-0941
1
E-GEOD-20719
Cxcl12
1
1
E-GEOD-7307
unknown
1
E-GEOD-7307
no estradiol
1
E-GEOD-20081
9 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
1
E-GEOD-19519
tunicamycin
1
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-2666, E-GEOD-4667

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-MTAB-73, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385

Genotype
studied in E-GEOD-22056, E-GEOD-17476, E-TABM-601, E-GEOD-17347

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-GEOD-21612, E-TABM-127, E-GEOD-9764, E-GEOD-10315, E-MEXP-1103 ... (5 experiments)

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-2069, E-GEOD-19330, E-TABM-666, ... (18 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-MEXP-561, E-GEOD-17400

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Media
studied in E-MEXP-765

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Population
studied in E-MTAB-197, E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-19445, E-GEOD-19246

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-10896

RNAi
studied in E-MEXP-2115, E-MEXP-1857

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-1643, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-33562, E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-12198 ... (5 experiments)

Tumor grading
studied in E-GEOD-4290

Processing time: 0.288 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM